Department Of Digestive & Liver Diseases
Investigator
Julia Wattacheril, MD, MPH
Email
jjw2151@cumc.columbia.edu
Dr. Wattacheril's clinical specialties include all aspects of transplant hepatology, general hepatology, and gastroenterology with emphasis on metabolic liver disease and obesity. She specializes in nonalcoholic fatty liver disease as well as all forms of hepatitis, chronic liver disease, and liver cancer in addition to liver transplantation. Her research interests include hepatic steatosis, insulin resistance, gut hormones and metabolic liver disease in adults. Her current research concentrates on the relationship between proteins and lipids that differentiate steatosis from steatohepatitis using an integrated omics approach.

Clinical Studies Managed By This Investigator:
Condition Study Title
Cirrhosis of the Liver [ CLOSED ] A Study of Subjects with Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatits (NASH) Study
Liver Disease [ CLOSED ] A study for patients with non-alcoholic steatohepatitis (NASH) fibrosis using study drug Emricasan
Liver Disease [ CLOSED ] Study of Drug in Patients with Primary Biliary Cholangitis (PBC)
NASH [ CLOSED ] Study of Obeticholic Acid in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH)
Liver Disease [ CLOSED ] A Study of Elafibranor in Patients with NASH and Fibrosis
Liver Disease Liver Health Study for Patients Undergoing Weight-Loss Surgery
Transplant [ CLOSED ] Observational Study for Patients with Cirrhosis and Hepatocellular Carcinoma (HCC) Undergoing a Liver Transplant
Liver Disease Using Gene Silencing to Treat Chronic Liver Disease Non-Alcoholic Steatohepatitis (NASH) in Adults at Increased Genetic Risk (NASHGEN-2)